홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → 6-(3,4-difluorophenyl)-3-[1-({4-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]phenyl}carbonyl)piperidin-4-yl]-1-[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione

HRID 1476559
노트
인쇄 미리보기

반응식

HRID 1476559 반응식
Cl.[F:2][C:3]1[CH:4]=[C:5]([C:10]2[S:18][C:17]3[C:16](=[O:19])[N:15]([CH:20]4[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]4)[C:14](=[O:26])[N:13]([CH2:27][C:28]4[O:32][N:31]=[C:30]([CH2:33][CH3:34])[N:29]=4)[C:12]=3[CH:11]=2)[CH:6]=[CH:7][C:8]=1[F:9].[CH2:35]([O:37][C:38]1[C:47]([O:48][CH3:49])=[CH:46][C:45]2[C:44]([C:50]3[CH:58]=[CH:57][C:53]([C:54](O)=[O:55])=[CH:52][CH:51]=3)=[N:43][C@@H:42]3[CH2:59][CH2:60][S:61][CH2:62][C@@H:41]3[C:40]=2[CH:39]=1)[CH3:36].C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C>CN(C=O)C>[F:2][C:3]1[CH:4]=[C:5]([C:10]2[S:18][C:17]3[C:16](=[O:19])[N:15]([CH:20]4[CH2:21][CH2:22][N:23]([C:54]([C:53]5[CH:57]=[CH:58][C:50]([C:44]6[C:45]7[CH:46]=[C:47]([O:48][CH3:49])[C:38]([O:37][CH2:35][CH3:36])=[CH:39][C:40]=7[C@H:41]7[CH2:62][S:61][CH2:60][CH2:59][C@H:42]7[N:43]=6)=[CH:51][CH:52]=5)=[O:55])[CH2:24][CH2:25]4)[C:14](=[O:26])[N:13]([CH2:27][C:28]4[O:32][N:31]=[C:30]([CH2:33][CH3:34])[N:29]=4)[C:12]=3[CH:11]=2)[CH:6]=[CH:7][C:8]=1[F:9]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 757711-HydroxybenzotriazoleHCID 672590924-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]benzoic acidHCID 709760686-(3,4-difluorophenyl)-1-[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl]-3-(piperidin-4-yl)thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione hydrochloride2회

생성물 1

HCID 70892444
6-(3,4-difluorophenyl)-3-[1-({4-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]phenyl}carbonyl)piperidin-4-yl]-1-[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

6-(3,4-difluorophenyl)-1-[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl]-3-(piperidin-4-yl)thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione hydrochloride (228 mg; compound B89) is reacted with 4-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]benzoic acid (191 mg; compound C10) and HOBt (74 mg) and EDCI (92 mg) in DMF (10 ml) according to the procedure described in example 46 to afford the title compound after purification by flash column chromatography [amino phase silica gel, eluation gradient: DCM/ethanol, 100/0/to 95/5 (v/v)] and by preparative HPLC as a solid.

출처 및 근거

ORD 기록
ord-ef79a9d735424ba3940cd7370ad6a28a
출처 데이터셋
uspto-grants-2015_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09018175B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트